Clinical Trial Update: Auto-HSCT-Supported Dose-Dense Chemotherapy with Adebrelimab As First-Line Treatment for ES-SCLC [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating auto-HSCT-supported dose-dense chemotherapy plus adebrelimab as first-line treatment for extensive-stage small cell lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Zhou Chengzhi | Conditions: Extensive Stage Small Cell Lung Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING